Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of nad with potent imp dehydrogenase-inhibitory properties
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (17) , 2633-2636
- https://doi.org/10.1016/0006-2952(83)90038-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Synthesis and antitumor activity of 2-.beta.-D-ribofuranosylselenazole-4-carboxamide and related derivativesJournal of Medicinal Chemistry, 1983
- Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide (NSC 286193)-IIBiochemical Pharmacology, 1982
- Mechanism of resistance to the oncolytic C-nucleoside 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC-286193)Biochemical Pharmacology, 1982
- The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1982
- The invitro inhibition of purine nucleotide biosynthesis by 2-β-D-ribofuranosylthiazole-4-carboxamideBiochemical and Biophysical Research Communications, 1981
- Fast atom bombardment of solids as an ion source in mass spectrometryNature, 1981
- 1H NMR SPECTROSCOPY OF SELENOSEMICARBAZIDES AND RELATED COMPOUNDSAnnals of the New York Academy of Sciences, 1972